+ Follow ATROVENT Tag
Array
(
[results] => Array
(
[0] => Array
(
[ArticleID] => 168699
[Title] => Breakthrough drug for COPD out
[Summary] => Two pharmaceutical companies, Boehringer Ingelheim and Pfizer, recently introduced Tiotropium, a novel drug that will provide remedy to patients suffering from Chronic Obstructive Pulmonary Disorder (COPD).
Tiotropium is the first once-daily inhaled therapy for the maintenance and treatment of COPD.
While it is less known than asthma, COPD is far more prevalent. World Health Organization (WHO) studies state that there are 600 million people suffering from COPD, although most remain undiagnosed.
[DatePublished] => 2002-07-18 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
)
)
ATROVENT
Array
(
[results] => Array
(
[0] => Array
(
[ArticleID] => 168699
[Title] => Breakthrough drug for COPD out
[Summary] => Two pharmaceutical companies, Boehringer Ingelheim and Pfizer, recently introduced Tiotropium, a novel drug that will provide remedy to patients suffering from Chronic Obstructive Pulmonary Disorder (COPD).
Tiotropium is the first once-daily inhaled therapy for the maintenance and treatment of COPD.
While it is less known than asthma, COPD is far more prevalent. World Health Organization (WHO) studies state that there are 600 million people suffering from COPD, although most remain undiagnosed.
[DatePublished] => 2002-07-18 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
)
)
abtest